FDA.reportPublic FDA data

LENIFEN

Manufacturer
CONTRAD SWISS SA | SIPRES SRL
Effective date
2021-01-11
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:57:12

Label at a glance#

ProductLENIFEN
Active ingredientAVENANTHRAMIDES, GLYCERIN
Label structure10 sections

Indications and uses

Temporarily protects and helps relieve minor skin irritation and itching due to: rashes eczema

Dosage and administration

Apply as needed. Apply a small quantity of product (press twice on the dispenser) on wet skin and gently massage. Rinse off and dry carefully.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Active ingredient Purpose

Glycerin 5% Skin protectant

Avenanthramides 0,05% Skin protectant

Purpose

OTC - PURPOSE SECTION

Skin Protectant

Uses

INDICATIONS & USAGE SECTION

Temporarily protects and helps relieve minor skin irritation and itching due to:

  • rashes
  • eczema

Warnings

WARNINGS SECTION

Avoid contact with eyes

WARNINGS AND PRECAUTIONS SECTION

Stop use and ask doctor if

OTC - STOP USE SECTION

condition worsen, symptoms persist for more than 7 days, or clear up and occur again within a few days.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply as needed.

Apply a small quantity of product (press twice on the dispenser) on wet skin and gently massage. Rinse off and dry carefully.

Other Information

ACCESSORIES

Store at room temperature 20-25° C (68-77° F) in a dry place, out of direct sunlight

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Beheneth-25, butylated hydroxytoluene, Butylene Glycol, Citric Acid, Dicaprylyl Ether, Disodium Edta, Hydrogenated Polyisobutene, Isopropyl Myristate, Oleyl Alcohol, Pentaerythrityl Distearate, Pentylene glycol, Phenoxyethanol,Simmondsia Chinensis Seed Oil, Sodium Polyacrylate, Sucrose Polystearate, Tocopheryl Acetate, Triticum Vulgare Germ Oil, Water, Zanthoxylum Bungeanum Fruit Extract.

Questions?

OTC - QUESTIONS SECTION

info@contrad.ch

ADVERSE REACTIONS SECTION

to report suspected adverse reactions contact 1-800-332-1088

Package. Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Lenifen LenitivaLenifen Lenitiva

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72582-00572582-005-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Name, UNII, Kind table
NameUNIIKind
PHENOXYETHANOLHIE492ZZ3TIACT
SIMMONDSIA CHINENSIS SEEDD24K2Q1F6HIACT
SUCROSE DISTEARATE33X4X4B90SIACT
AVENANTHRAMIDES5PA41O4AITACTIB
.ALPHA.-TOCOPHEROL ACETATE9E8X80D2L0IACT
WHEAT GERMYR3G369F5AIACT
WATER059QF0KO0RIACT
ZANTHOXYLUM ARMATUM FRUITER3FV125H7IACT
BUTYLENE GLYCOL3XUS85K0RAIACT
DICAPRYLYL ETHER77JZM5516ZIACT
MAGNESIUM DISODIUM EDTANDT563S5VZIACT
HYDROGENATED POLYBUTENE (1300 MW)7D1YQ9Y5EZIACT
HYDROXYPHENYL PROPAMIDOBENZOIC ACID25KRT26H77IACT
ISOPROPYL MYRISTATE0RE8K4LNJSIACT
OLEYL ALCOHOL172F2WN8DVIACT
PENTAERYTHRITYL DISTEARATE697WOT8HNBIACT
PENTYLENE GLYCOL50C1307PZGIACT
SODIUM POLYACRYLATE (8000 MW)285CYO341LIACT
GLYCERINPDC6A3C0OXACTIB
BEHENETH-250G17KJ5M7PIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c6fea1d0-8c42-90f6-e053-2a95a90aee9081dd93a4-6fc7-cb4a-e053-2a91aa0a3faf2021-07-13Warnings, Adverse reactionsExact identifier
spl set id: 81dd93a4-6fc7-cb4a-e053-2a91aa0a3faf

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.